Proper clinical counter-measures for multi-drug resistant bacteria

National Medical Journal of China

Volumn 90, Issue 46, 2010, Pages 3244-3246

  Liu, You Ning ^a   She, Dan Yang ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM; MICROBIOLOGICAL PARAMETERS; MULTIDRUG RESISTANT BACTERIUM; NONHUMAN; CLASSIFICATION; DRUG EFFECT; MULTIDRUG RESISTANCE;

BACTERIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL;

EID: 84871438342     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.46.002     Document Type: Article

References (15)

1. Yong D, Toleman M A, Giske C G, et al. Characterization of a new metallo-beta-lactamase gene, bla (NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother December, 2009, 53: 5046-5054.
2. Kumarasamy K K, Toleman M A, Walsh T R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis, 2010, 10: 597-602.
3. Jacoby G A, Munoz-Price L S. The new β-lactamases. N Engl J Med, 2005, 352: 380-391.
4. Bush K, Jacoby G A. Updated functional classification of beta-lactamases. Avian Dis, 2010, 54: 969-976.
5. Walsh T R, Toleman M A, Poirel L, et al. Metallo-beta-lactamase: the quiet before the storm? Clin Microbiol Rev, 2005, 18: 306-325.
6. Carmeli Y, Akova M, Cornaglia G, et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect, 2010, 16: 102-111.
7. Boucher H W, Talbot G H, Bradley J S, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis, 2009, 48: 1-12.
8. Klevens R M, Morrison M A, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA, 2007, 298: 1763-1771.
9. Morozumi M, Iwata S, Hasegawa K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob Agents Chemother, 2008, 52: 348-350.
10. Pereyre S, Charron A, Renaudin H, et al. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol, 2007, 45: 3534-3539.
11. Dumke R, von Baum H, Luck P C, et al. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect, 2010, 16: 613-616.
12. Wolff B J, Thacker W L, Schwartz S B, et al. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother, 2008, 52: 3542-3549.
13. Xin D, Mi Z, Han X, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. Antimicrob Agents Chemother, 2009, 53: 2158-2159.
14. Liu Y, Ye X, Zhang H, et al. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis on macrolide-resistant strains from Shanghai, China. Antimicrob Agents Chemother, 2009, 53: 2160-2162.
15. Cao B, Zhao C J, Yin Y D, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis, 2010, 51: 189-194.